Low-dose-rate brachytherapy as a minimally invasive curative treatment for localised prostate cancer has excellent oncological and functional outcomes: a retrospective analysis from a single centre

about

Low-dose-rate brachytherapy as a minimally invasive curative treatment for localised prostate cancer has excellent oncological and functional outcomes: a retrospective analysis from a single centre

Item

http://www.wikidata.org/entity/Q58578875

description

scientific article published on 22 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Low-dose-rate brachytherapy as ...... analysis from a single centre

@en

Low-dose-rate brachytherapy as ...... analysis from a single centre

@nl

type

Item

label

Low-dose-rate brachytherapy as ...... analysis from a single centre

@en

Low-dose-rate brachytherapy as ...... analysis from a single centre

@nl

prefLabel

Low-dose-rate brachytherapy as ...... analysis from a single centre

@en

Low-dose-rate brachytherapy as ...... analysis from a single centre

@nl

P1476

Low-dose-rate brachytherapy as ...... analysis from a single centre

@en

P2093

Diederik Ponette

http://www.w3.org/2001/XMLSchema#string

Jochen Darras

http://www.w3.org/2001/XMLSchema#string

Lorenzo Staelens

http://www.w3.org/2001/XMLSchema#string

Pieter Mattelaer

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Importance of post-implant dosimetry in permanent prostate brachytherapy.

Prostate-specific antigen bounce after prostate brachytherapy: review of a confusing phenomenon.

Global Incidence and Mortality for Prostate Cancer: Analysis of Temporal Patterns and Trends in 36 Countries.

Prostate-specific antigen bounce after prostate seed implantation for localized prostate cancer: descriptions and implications.

Permanent 125I-seed prostate brachytherapy: early prostate specific antigen value as a predictor of PSA bounce occurrence.

Favourable long-term outcomes with brachytherapy-based regimens in men ≤60 years with clinically localized prostate cancer.

Population-based 10-year oncologic outcomes after low-dose-rate brachytherapy for low-risk and intermediate-risk prostate cancer.

Long-term oncological outcomes and toxicity in 597 men aged ≤60 years at time of low-dose-rate brachytherapy for localised prostate cancer.

Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up.

P304

270-275

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5173/CEJU.2018.1749

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hans Pottel

Pieter D'Hulst

P577

2018-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30386646

http://www.w3.org/2001/XMLSchema#string

P921

brachytherapy

P932

6202624

http://www.w3.org/2001/XMLSchema#string